Translating the diabetes prevention program into practice in the general community: Findings from the Montana cardiovascular disease and diabetes prevention program

Diabetes Educator

Volumn 35, Issue 2, 2009, Pages 209-223

  Amundson, Helen A ^a   Butcher, Marcene K ^a   Gohdes, Dorothy ^a   Hall, Taryn O ^a   Harwell, Todd S ^a,b   Helgerson, Steven D ^a   Vanderwood, Karl K ^a  

^a Montana Cardiovascular Disease and Diabetes Prevention Program Workgroup

^b MONTANA DEPARTMENT OF PUBLIC HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; COMMUNITY CARE; DIABETES MELLITUS; EXERCISE; FEMALE; GENETICS; GOVERNMENT; HUMAN; MALE; MIDDLE AGED; MOTOR ACTIVITY; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; SELF CARE; UNITED STATES; WEIGHT REDUCTION;

ADULT; AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COMMUNITY HEALTH SERVICES; DIABETES MELLITUS; EXERCISE; FEMALE; HUMANS; MALE; MIDDLE AGED; MONTANA; MOTOR ACTIVITY; PATIENT EDUCATION AS TOPIC; SELF CARE; UNITED STATES; UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES; WEIGHT LOSS;

EID: 63849205402     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721709333269     Document Type: Article

References (33)

1. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF Lifetime risk for diabetes mellitus in the United States. JAMA. 2003 ; 290 (14). 1884-1890.
2. Knowler WC, Barrett-Connor E., Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 ; 346: 393-403.
3. Ratner R., Goldberg R., Haffner S., et al. Diabetes Prevention Program Research Group. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care. 2005 ; 28 (4). 888-894.
4. Orchard TJ, Temprosa M., Goldberg R., et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med. 2005 ; 142 (8). 611-619.
5. Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002 ; 25: 2165-2171.
6. Diabetes Prevention Program Research Group. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care. 2003 ; 26 (9). 2518-2523.
7. Herman WH, Hoerger TJ, Brandle M., et al. Diabetes Prevention Program Research Group. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005 ; 142 (5). 323-332.
8. Ackermann RT, Marrero DG Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: the YMCA model. Diabetes Educ. 2007 ; 33 (1). 69, 74-75, 77-78.
9. Pagoto SL, Kantor L., Bodenlos JS, Gitkind M., Ma Y. Translating the diabetes prevention program into a hospital-based weight loss program. Health Psychol. 2008 ; 27 (1 suppl). S91 - S98.
10. Aldana S., Barlow M., Smith R., et al. A worksite diabetes prevention program: two-year impact on employee health. AAOHN J. 2006 ; 54: 389-395.
11. Boltri JM, Davis-Smith YM, Seale JP, Shellenberger S., Okosun IS, Cornelius ME Diabetes prevention in a faith-based setting: results of translational research. J Public Health Manag Pract. 2008 ; 14 (1). 29-32.
12. Seidel MC, Powell RO, Zgibor JC, Siminerio LM, Piatt GA Translating the Diabetes Prevention Program into an urban medically underserved community: a nonrandomized prospective intervention study. Diabetes Care. 2008 ; 31 (4). 684-689.
13. Roubideaux Y., Beals J., Jiang L., Valdez SL, Manson SM, Acton K. Special diabetes programs for Indians diabetes prevention program: translating research into practice for American Indians and Alaska natives at risk for diabetes. Diabetes Care. 2008 ; 57 (suppl 1). A248. Abstract 859-P.
14. Cramer JS, Sibley RF, Bartlett DP, Kahn LS, Loffredo L. An adaptation of the diabetes prevention program for use with high-risk, minority patients with type 2 diabetes. Diabetes Educ. 2007 ; 33 (3). 503-508.
15. Eckel RH Preventive cardiology by lifestyle intervention: opportunity and/or challenge? Presidential address at the 2005 American Heart Association Scientific Sessions. Circulation. 2006 ; 113 (22). 2657-2661.
16. Gotto AM Jr, Blackburn GL, Dailey GE III, et al. The metabolic syndrome: a call to action. Coron Artery Dis. 2006 ; 17 (1). 77-80.
17. Grundy SM Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol. 2006 ; 47 (6). 1093-100.
18. Eckel RH, Kahn R., Robertson RM, Rizza RA Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation. 2006 ; 113 (25). 2943-2946.
19. Gohdes D., Amundson H., Oser CS, Helgerson SD, Harwell TS How are we diagnosing and treating cardiometabolic risk in Montana? Prim Care Diabetes. Epub ahead of print, January 19, 2009.
20. US Bureau of the Census. http://factfinder.census.gov/. Accessed July 16, 2008.
21. Healthy Native Community Partnership. Native lifestyle balance curriculum. http://www.hncp.org/wst/hpdp/NLB. Accessed July 28, 2008.
22. Ackermann RT, Finch EA, Brizendine E., Zhou H., Marrero DG Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. Am J Prev Med. 2008 ; 35 (4). 357-363.
23. Hollis JF, Gullion CM, Stevens VJ, et al. Weight Loss Maintenance Trial Research Group. Weight loss during the intensive intervention phase of the weight-loss maintenance trial. Am J Prev Med. 2008 ; 35 (2). 118-126.
24. Wilson PW, D'Agostino RB, Parise H., Sullivan L., Meigs JB Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005 ; 112 (20). 3066-3072.
25. National Institutes of Health. Clinical guidelines on the identification, evaluation, treatment of overweight and obesity in adults: the evidence report. Obes Res. 1998 ; 6 (suppl 2). 51S - 209S.
26. US Department of Health and Human Services. Physical Activity and Health: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention ; 1996.
27. Lindström J., Ilanne-Parikka P., Peltonen M., et al. Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006 ; 368 (9548). 1673-1679.
28. Li G., Zhang P., Wang J., Gregg EW, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008 ; 371 (9626). 1783-1789.
29. Rosenzweig JL, Ferrannini E., Grundy SM, et al. Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008 ; 93 (10). 3671-3689.
30. Garber AJ, Handelsman Y., Einhorn D., et al. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract. 2008 ; 14 (7). 933-946.
31. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008 ; 359: 1577-1589.
32. Ackermann RT, Marrero DG, Hicks KA, et al. An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes. Diabetes Care. 2006 ; 29 (6). 1237-1241.
33. Mensing C., Boucher J., Cypress M., et al. National standards for diabetes self-management education. Diabetes Care. 2007 ; 30 (suppl 1). S96 - S103.